GapMind for catabolism of small carbon sources

 

myo-inositol catabolism in Ochrobactrum rhizosphaerae PR17

Best path

PGA1_c07300, PGA1_c07310, PGA1_c07320, iolG, iolE, iolD, iolB, iolC, iolJ, mmsA, tpi

Rules

Overview: Myo-inositol degradation in GapMind is based on MetaCyc pathways myo-inositol degradation I via inosose dehydratase (link) and pathway II inosose dehydrogenase (link).

29 steps (19 with candidates)

Or see definitions of steps

Step Description Best candidate 2nd candidate
PGA1_c07300 myo-inositol ABC transport, substrate-binding component
PGA1_c07310 myo-inositol ABC transporter, permease component CEV32_RS13215 CEV32_RS07885
PGA1_c07320 myo-inositol ABC transporter, ATPase component CEV32_RS13210 CEV32_RS07820
iolG myo-inositol 2-dehydrogenase CEV32_RS03610 CEV32_RS13225
iolE scyllo-inosose 2-dehydratase CEV32_RS03590
iolD 3D-(3,5/4)-trihydroxycyclohexane-1,2-dione hydrolase CEV32_RS03595
iolB 5-deoxy-D-glucuronate isomerase CEV32_RS03585
iolC 5-dehydro-2-deoxy-D-gluconate kinase CEV32_RS03600
iolJ 5-dehydro-2-deoxyphosphogluconate aldolase CEV32_RS03600 CEV32_RS07835
mmsA malonate-semialdehyde dehydrogenase CEV32_RS16950 CEV32_RS21345
tpi triose-phosphate isomerase CEV32_RS12145 CEV32_RS07845
Alternative steps:
eda 2-keto-3-deoxygluconate 6-phosphate aldolase CEV32_RS22855 CEV32_RS06975
HMIT myo-inositol:H+ symporter
iatA myo-inositol ABC transporter, ATPase component IatA CEV32_RS01950 CEV32_RS06960
iatP myo-inositol ABC transporter, permease component IatP CEV32_RS05365 CEV32_RS01955
ibpA myo-inositol ABC transporter, substrate-binding component IbpA
iolF myo-inositol:H+ symporter
iolM 2-inosose 4-dehydrogenase
iolN 2,4-diketo-inositol hydratase
iolO 5-dehydro-L-gluconate epimerase
iolT myo-inositol:H+ symporter
kdgK 2-keto-3-deoxygluconate kinase CEV32_RS10340 CEV32_RS01960
PS417_11885 myo-inositol ABC transporter, substrate-binding component CEV32_RS07025 CEV32_RS14765
PS417_11890 myo-inositol ABC transporter, ATPase component CEV32_RS05960 CEV32_RS01950
PS417_11895 myo-inositol ABC transporter, permease component CEV32_RS07925 CEV32_RS07885
SMIT1 myo-inositol:Na+ symporter
uxaE D-tagaturonate epimerase
uxuA D-mannonate dehydratase CEV32_RS02595
uxuB D-mannonate dehydrogenase CEV32_RS02590 CEV32_RS03540

Confidence: high confidence medium confidence low confidence
transporter – transporters and PTS systems are shaded because predicting their specificity is particularly challenging.

This GapMind analysis is from Sep 24 2021. The underlying query database was built on Sep 17 2021.

Links

Downloads

Related tools

About GapMind

Each pathway is defined by a set of rules based on individual steps or genes. Candidates for each step are identified by using ublast (a fast alternative to protein BLAST) against a database of manually-curated proteins (most of which are experimentally characterized) or by using HMMer with enzyme models (usually from TIGRFam). Ublast hits may be split across two different proteins.

A candidate for a step is "high confidence" if either:

where "other" refers to the best ublast hit to a sequence that is not annotated as performing this step (and is not "ignored").

Otherwise, a candidate is "medium confidence" if either:

Other blast hits with at least 50% coverage are "low confidence."

Steps with no high- or medium-confidence candidates may be considered "gaps." For the typical bacterium that can make all 20 amino acids, there are 1-2 gaps in amino acid biosynthesis pathways. For diverse bacteria and archaea that can utilize a carbon source, there is a complete high-confidence catabolic pathway (including a transporter) just 38% of the time, and there is a complete medium-confidence pathway 63% of the time. Gaps may be due to:

GapMind relies on the predicted proteins in the genome and does not search the six-frame translation. In most cases, you can search the six-frame translation by clicking on links to Curated BLAST for each step definition (in the per-step page).

For more information, see:

If you notice any errors or omissions in the step descriptions, or any questionable results, please let us know

by Morgan Price, Arkin group, Lawrence Berkeley National Laboratory